IRIS
NG, KIU YAN CHARLOTTE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.961
NA - Nord America 2.633
SA - Sud America 602
EU - Europa 382
AF - Africa 72
OC - Oceania 8
Totale 6.658
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.530
SG - Singapore 1.758
CN - Cina 568
BR - Brasile 497
VN - Vietnam 251
HK - Hong Kong 143
IT - Italia 80
GB - Regno Unito 58
DE - Germania 52
IN - India 47
CA - Canada 40
FR - Francia 38
BD - Bangladesh 37
MX - Messico 37
AR - Argentina 36
RU - Federazione Russa 27
TR - Turchia 23
ZA - Sudafrica 22
EC - Ecuador 21
PL - Polonia 20
VE - Venezuela 20
IQ - Iraq 19
NL - Olanda 16
FI - Finlandia 15
UZ - Uzbekistan 14
IE - Irlanda 12
JP - Giappone 12
SA - Arabia Saudita 12
CL - Cile 10
ES - Italia 10
MY - Malesia 10
PH - Filippine 10
PK - Pakistan 10
KE - Kenya 9
CR - Costa Rica 8
MA - Marocco 8
SE - Svezia 8
CZ - Repubblica Ceca 7
ID - Indonesia 7
NG - Nigeria 7
UA - Ucraina 7
AU - Australia 6
DZ - Algeria 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
HN - Honduras 5
LB - Libano 5
LV - Lettonia 5
PY - Paraguay 5
AZ - Azerbaigian 4
BO - Bolivia 4
NP - Nepal 4
TN - Tunisia 4
AM - Armenia 3
BE - Belgio 3
EG - Egitto 3
ET - Etiopia 3
IL - Israele 3
JM - Giamaica 3
KG - Kirghizistan 3
LT - Lituania 3
RO - Romania 3
SN - Senegal 3
AL - Albania 2
BG - Bulgaria 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
JO - Giordania 2
LU - Lussemburgo 2
MG - Madagascar 2
NI - Nicaragua 2
PE - Perù 2
SV - El Salvador 2
TH - Thailandia 2
UY - Uruguay 2
AO - Angola 1
AT - Austria 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BT - Bhutan 1
BY - Bielorussia 1
CD - Congo 1
CH - Svizzera 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GI - Gibilterra 1
GR - Grecia 1
GT - Guatemala 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
Totale 6.653
Salva come PNG Salva come JPEG
Città #
Singapore 725
San Jose 513
Ashburn 430
The Dalles 290
New York 250
Shanghai 246
Dallas 159
Beijing 151
Hong Kong 139
Ho Chi Minh City 94
Los Angeles 86
Santa Clara 62
Hanoi 56
São Paulo 45
Buffalo 44
Boardman 37
Wilmington 26
Milan 24
San Mateo 21
Orem 20
Johannesburg 18
Brooklyn 17
Mexico City 17
Warsaw 17
Chennai 16
Chicago 16
Da Nang 15
Munich 15
Rio de Janeiro 15
Frankfurt am Main 14
Helsinki 14
Tashkent 14
Seattle 12
Tokyo 12
Paris 11
Toronto 11
Belo Horizonte 10
London 10
Boston 9
Brasília 9
Guayaquil 9
San Francisco 9
Abbiategrasso 8
Ankara 8
Atlanta 8
Denver 8
Dublin 8
Fortaleza 8
Haiphong 8
Lissone 8
Manchester 8
Nairobi 8
Charlotte 7
Council Bluffs 7
Kuala Lumpur 7
Lawrence 7
Princeton 7
San José 7
Amsterdam 6
Baghdad 6
Brno 6
Buenos Aires 6
Campinas 6
Chandler 6
Dhaka 6
Erbil 6
Fairfield 6
Goiânia 6
Guarulhos 6
Houston 6
Hải Dương 6
Phoenix 6
Sydney 6
Benin City 5
Istanbul 5
Maracaibo 5
Moscow 5
Poplar 5
Porto Alegre 5
Quito 5
Recife 5
Riga 5
Riyadh 5
Salvador 5
Stockholm 5
Assago 4
Biên Hòa 4
Casablanca 4
Colombo 4
Curitiba 4
Hangzhou 4
Jeddah 4
Joinville 4
Maceió 4
Mauá 4
Montreal 4
Mumbai 4
Natal 4
Piracicaba 4
Reston 4
Totale 4.040
Salva come PNG Salva come JPEG
Nome #
High expression of HOXA13 correlates with poorly differentiated hepatocellular carcinomas and modulates sorafenib response in in vitro models 97
Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast 72
Circulating Cell-Free DNA Captures the Intratumor Heterogeneity in Multinodular Hepatocellular Carcinoma 72
Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies 72
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: A proof-of-principle 71
PI3K inhibition circumvents resistance to SHP2 blockade in metastatic triple-negative breast cancer 70
Adenylosuccinate lyase is oncogenic in colorectal cancer by causing mitochondrial dysfunction and independent activation of NRF2 and mTOR-MYC-axis 68
A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations 66
A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) 66
A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancer 64
Metaplastic breast carcinoma: more than a special type 64
Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma 63
Prognostic signatures in breast cancer: correlation does not imply causation 61
Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancer 61
Combining two antibodies to define E-cadherin loss of expression in non-lobular breast carcinomas: when less is more 61
Breast cancer intratumor genetic heterogeneity: causes and implications 60
Genomic landscape of adenoid cystic carcinoma of the breast 60
Alterations in Homologous Recombination Repair Genes in Prostate Cancer Brain Metastases 60
Genetic profiling using plasma-derived cell-free DNA in therapy-naive hepatocellular carcinoma patients: A pilot study 60
APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas 59
Bi-allelic alterations in DNA repair genes underpin homologous recombination DNA repair defects in breast cancer 59
Integrative genomic and transcriptomic characterization of papillary carcinomas of the breast 58
Molecular classification of hepatocellular carcinoma: The view from metabolic zonation 58
Cancer Diagnosis Using a Liquid Biopsy: Challenges and Expectations 58
Breast cancer intra-tumor heterogeneity 57
The Genomic Landscape of Male Breast Cancers 56
The protein histidine phosphatase LHPP is a tumour suppressor 55
Genetic Alterations in Benign Breast Biopsies of Subsequent Breast Cancer Patients 54
Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast 54
Genomic characterization of metastatic breast cancers 53
Circulating Cell-Free DNA in Hepatocellular Carcinoma: Current Insights and Outlook 53
Structural analysis of the genome of breast cancer cell line ZR-75-30 identifies twelve expressed fusion genes 53
SCIM: universal single-cell matching with unpaired feature sets 53
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer 52
Hepatocellular Carcinoma Immune Microenvironment Analysis: A Comprehensive Assessment with Computational and Classical Pathology 52
The Genomic Landscape of Serrated Lesion of the Colorectum: Similarities and Differences With Tubular and Tubulovillous Adenomas 52
Predictive performance of microarray gene signatures: impact of tumor heterogeneity and multiple mechanisms of drug resistance 51
Genomic Analysis Revealed New Oncogenic Signatures in TP53-Mutant Hepatocellular Carcinoma 51
Pregnancy at early age is associated with a reduction of progesterone-responsive cells and epithelial Wnt signaling in human breast tissue 50
HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2(+) Breast Cancer 50
Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib 50
ESR1 and endocrine therapy resistance: more than just mutations 50
The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support 50
Benchmarking mutation effect prediction algorithms using functionally validated cancer-related missense mutations 50
The Role of Long Non-Coding RNAs in Hepatocarcinogenesis 49
Are acinic cell carcinomas of the breast and salivary glands distinct diseases? 49
Massively parallel sequencing analysis of synchronous fibroepithelial lesions supports the concept of progression from fibroadenoma to phyllodes tumor 49
PIKing the type and pattern of PI3K pathway mutations in endometrioid endometrial carcinomas 49
Phyllodes tumors with and without fibroadenoma-like areas display distinct genomic features and may evolve through distinct pathways 49
Genomic profiling of histological special types of breast cancer 49
Patient-derived xenografts and organoids model therapy response in prostate cancer 49
Detection of isoforms and genomic alterations by high-throughput full-length single-cell RNA sequencing in ovarian cancer 49
Proteasome Addiction Defined in Ewing Sarcoma Is Effectively Targeted by a Novel Class of 19S Proteasome Inhibitors 48
Transcriptional Enhancer Factor Domain Family member 4 Exerts an Oncogenic Role in Hepatocellular Carcinoma by Hippo-Independent Regulation of Heat Shock Protein 70 Family Members 48
Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responses 48
Chromosomal instability determines taxane response 48
NGS-pipe: a flexible, easily extendable and highly configurable framework for NGS analysis 48
Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma 47
Vascular endothelial growth factor A amplification in colorectal cancer is associated with reduced M1 and M2 macrophages and diminished PD-1-expressing lymphocytes 47
The Landscape of Somatic Genetic Alterations in Metaplastic Breast Carcinomas 46
PI3K pathway activation in high-grade ductal carcinoma in situ--implications for progression to invasive breast carcinoma 46
The role of tandem duplicator phenotype in tumour evolution in high-grade serous ovarian cancer 46
Resolving quandaries: basaloid adenoid cystic carcinoma or breast cylindroma? The role of massively parallel sequencing 46
Diagnostic Targeted Sequencing Panel for Hepatocellular Carcinoma Genomic Screening 46
Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression 46
The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study 45
Targeted capture massively parallel sequencing analysis of LCIS and invasive lobular cancer: Repertoire of somatic genetic alterations and clonal relationships 45
Epigenetic priming in chronic liver disease impacts the transcriptional and genetic landscapes of hepatocellular carcinoma 45
Stroma Transcriptomic and Proteomic Profile of Prostate Cancer Metastasis Xenograft Models Reveals Prognostic Value of Stroma Signatures 45
Multi-omics data integration reveals novel drug targets in hepatocellular carcinoma 45
Hepatocellular Carcinoma Xenografts Established From Needle Biopsies Preserve the Characteristics of the Originating Tumors 45
Tandem duplication of chromosomal segments is common in ovarian and breast cancer genomes 45
RNASeq analysis reveals biological processes governing the clinical behaviour of endometrioid and serous endometrial cancers 45
PipeIT: A Singularity Container for Molecular Diagnostic Somatic Variant Calling on the Ion Torrent Next-Generation Sequencing Platform 45
Standardizing Patient-Derived Organoid Generation Workflow to Avoid Microbial Contamination From Colorectal Cancer Tissues 45
Breast cancer genomics from microarrays to massively parallel sequencing: paradigms and new insights 45
Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer 44
Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis 44
Deciphering the clonal relationship between glandular and squamous components in adenosquamous carcinoma of the lung using whole exome sequencing 44
Infiltration by IL22-Producing T Cells Promotes Neutrophil Recruitment and Predicts Favorable Clinical Outcome in Human Colorectal Cancer 44
SF3B1 mutations constitute a novel therapeutic target in breast cancer 44
Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages 44
Expression of RET is associated with Oestrogen receptor expression but lacks prognostic significance in breast cancer 44
Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands 44
PipeIT2: A tumor-only somatic variant calling workflow for molecular diagnostic Ion Torrent sequencing data 44
Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases 44
Contralateral breast cancers: Independent cancers or metastases? 43
Progression from ductal carcinoma in situ to invasive breast cancer: revisited 43
HMGA1 Expression in Human Hepatocellular Carcinoma Correlates with Poor Prognosis and Promotes Tumor Growth and Migration in in vitro Models 43
Nectin-4 Expression Is an Independent Prognostic Biomarker and Associated With Better Survival in Triple-Negative Breast Cancer 42
Discovery of heterozygous KRT10 alterations in MAUIE cases underlines the importance of regular skin cancer screening in ichthyosis with confetti 42
Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer 42
Metaplastic breast carcinomas display genomic and transcriptomic heterogeneity [corrected] 42
Establishing the origin of metastatic deposits in the setting of multiple primary malignancies: the role of massively parallel sequencing 42
Gene expression profiling of lobular carcinoma in situ reveals candidate precursor genes for invasion 42
Mechanism of action of a WWTR1(TAZ)-CAMTA1 fusion oncoprotein 41
Uterine adenosarcomas are mesenchymal neoplasms 41
Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samples 41
TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers 41
Infiltrating epitheliosis of the breast: characterization of histological features, immunophenotype and genomic profile 41
Totale 5.129
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.194
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.194
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202113 0 0 0 0 0 0 0 0 0 0 0 13
2021/202232 0 0 0 10 0 0 0 7 1 1 5 8
2022/202344 14 0 7 1 4 1 0 3 5 7 2 0
2023/2024767 1 4 5 2 0 339 54 56 14 10 112 170
2024/20251.492 27 5 8 20 11 171 87 96 318 426 158 165
2025/20264.433 624 379 168 384 123 249 1.206 215 181 339 340 225
Totale 6.825